Animal Health Investment USA is a premier investment forum showcasing the most exciting partner opportunities in animal health and connecting those businesses together with financial investors and strategic corporate partners. […]

Off the back of the newly released first-in-human data utilizing PROTACs, it is more than ever evident that the field of targeted protein degradation is redefining the therapeutic landscape across […]

The Congress will explore novel strategies and developments in plant genomics and gene editing through a series of case studies and an examination of the latest scientific research. Leaders from […]

Case studies across the two days will examine developments in biopesticides and biostimulants and the application of new research in increasing crop yield, improving soil health & nutrient uptake, and […]

The meeting will examine the symbiotic relationships between microbes and plants through case studies in plant and soil microbiomes. Academic and industry leaders will discuss new research into the rhizosphere, […]

The 5th Microbiome Movement – Drug Development Summit (October 19-21, Digital Event - EDT) continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community […]

After the challenges of 2020 with the Covid-19 pandemic, this is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for […]

SMi are proud to announce the 7th annual conference: Pre-Filled Syringes East Coast 2020 26-27 October 2020 Boston, USA Sheraton Boston Hotel http://www.pfsamericas.com/pjwl Innovations in parenteral device and product development SMi […]

Smithers’ 9th annual Extractables and Leachables USA conference is returning. This is a unique event in the extractables and leachables industry, bringing together top companies from the entire supply chain and making […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a […]

Realise the Commercial Potential of Gene Therapies The 4th Annual Gene Therapy for Rare Disorders Europe is dedicated to overcoming manufacturing, clinical, and commercialisation challenges drug developers face when delivering gene therapies to market. With new European […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a […]

Harnessing the Potential of Macrophage Therapies Using Small Molecule, Antibody & Cell Therapy based Approaches for Oncology and Beyond With the explosive excitement and clinical proof of concepts utilizing CD47 […]

SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference: 28 – 29 October 2020 Location: Virtual Event Website: www.microbiologyeastcoast.com/PJWL SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, C.T.L. MAT, LONZA CHAIRED BY: Lynne Ensor,VP Technical, […]

Finding new therapeutics to counter the progression of Dry AMD and prevent the geographical atrophy has never been more important. The aging population creates an ever-growing clinical need for next-generation […]

Achieving Standardization & Operational Excellence in Vein-to-Vein Supply As an increasing number of candidates enter the clinic and promise to be a mainstay in the future of cancer treatment, cell […]

With all eyes on the explosive neoantigen field watching to see how it can revolutionize cancer immunotherapies and rival the current T cell therapies, it is clear that critical questions […]

This forum has a long-standing reputation for bringing together leading academic and industry microbiome researchers. Presentations will feature the latest research into the human microbiome as well as effective business […]

This congress will explore the burgeoning field of skin microbiome research, with case studies focused on topics such atopic dermatitis, psoriasis, acne, and allergy, and the microbiome-based products being developed […]

This Congress will include numerous presentations on probiotics discovery and product development, as well as prebiotics, diet and nutrition. Alongside several case studies on digestive health, metabolic diseases, ageing and […]

The 3rd Lab Asset & Facility Management in Pharma will return to Boston this Winter as your ONLY industry led meeting focusing on R&D asset and FM, enabling you to regain control of […]

The 3rd Annual Neuropsychiatric Drug Development Summit will return in November 2020 as an interactive, virtual meeting. This definitive industry meeting is focused on helping you develop the next generation […]

Europe's #1 forum for oligonucleotide, peptide, CRISPR and mRNA therapeutic leaders to discuss scientific strategies and accelerate products to market, while also creating new successful partnerships. This year's virtual agenda […]

The Digital 2nd Annual Biomarkers for Rare Non-Oncological Diseases Summit will unite biopharma, diagnostic and healthcare teams to advance the application of precision medicine in rare diseases beyond oncology. This event is […]

2019 proved to be a pivotal year for the skin microbiome, as personal care giants Unilever launched their Dove range of ‘microbiome-friendly’ skincare products. Clearly, the biggest players in beauty […]

The exosome therapeutics field is booming with anticipation as preparations are underway for the first few clinical trials and money pours in through partnerships and pipeline acquisitions. However, more is […]

Microbiome Connect: Human EU has been postponed this year due to the impacts of COVID-19.  However, at Microbiome Connect, we’re committed to continue providing a platform for scientific presentations and […]

This Summit is designed to create a collaborative environment in which attendees engaged with the speakers, sponsors and other delegates in attendance. The meeting agenda has expanded to include: AI […]

This Summit will focus its attention to some of the leading issues in Medicinal Chemistry today. This year the conference has expanded its coverage on protein degradation and will have […]

With about 85% of the proteome currently undrugged, accessing these targets that are, at present, extremely difficult to drug, has prevented researchers from achieving desired clinical successes. The 2nd Proteome- […]